# RALGDS

## Overview
RALGDS (ral guanine nucleotide dissociation stimulator) is a gene that encodes a guanine nucleotide exchange factor (GEF) protein involved in the regulation of small GTPases, particularly RalA and RalB. The RALGDS protein plays a pivotal role in cellular signaling pathways by facilitating the exchange of GDP for GTP, thereby activating Ral GTPases, which are crucial for various cellular processes such as vesicle trafficking, cytoskeletal dynamics, and gene expression (Ferro2010RalGDS; Albright1993Characterization). Structurally, RALGDS contains a Ras-binding domain (RBD) and a GEF domain, which enable it to interact with Ras and Ral proteins, linking Ras signaling to Ral activation (Huang1996Crystallization; Kikuchi1994ralGDS). The protein's activity is modulated by its translocation to the plasma membrane upon activation by Ras, a process that is enhanced by calcium-dependent interactions with calmodulin (Matsubara1999Plasma). Clinically, alterations in RALGDS expression are associated with cancer progression, making it a potential therapeutic target due to its role in promoting cancer cell invasion and migration (Shirakawa2015Ral; Richardson2022The).

## Structure
The RALGDS protein, a guanine nucleotide dissociation stimulator, plays a crucial role in signal transduction pathways by interacting with Ras and Ral GTPases. Structurally, RALGDS contains several important domains, including the Ras-binding domain (RBD) and the guanine nucleotide exchange factor (GEF) domain. The C-terminal domain of RALGDS (C-RalGDS) is particularly significant as it binds tightly to the effector loop of Ras, suggesting its role as a crossing point between the Ras and Ral signaling pathways (Huang1996Crystallization).

The crystallization and preliminary crystallographic analysis of the C-RalGDS have shown that the crystals diffract to 1.8 Å, providing detailed insights into its structure (Huang1996Crystallization). Molecular dynamics simulations have revealed significant conformational changes in the RalGDS structure, particularly in the region of amino acids D26 to G28, with an average root mean square deviation (rmsd) of 3.0 Å (Gohlke2003Insights). The Ras-RalGDS complex exhibits specific interactions, including hydrogen bonds and salt bridges, involving residues such as I24, N23, and D33, which are crucial for its binding affinity (Gohlke2003Insights). These structural insights are essential for understanding the protein's function and for the potential design of specific inhibitors targeting Ras interactions.

## Function
RALGDS (ral guanine nucleotide dissociation stimulator) is a guanine nucleotide exchange factor (GEF) that plays a critical role in the activation of Ral GTPases, specifically RalA and RalB, by facilitating the exchange of GDP for GTP. This activation is essential for various cellular processes, including vesicle trafficking, cytoskeletal dynamics, and gene expression (Ferro2010RalGDS; Albright1993Characterization). In endothelial cells, RALGDS is involved in the exocytosis of Weibel-Palade bodies (WPBs), which are storage organelles containing bioactive compounds like von Willebrand factor. This process is crucial for vascular function and hemostasis, as RALGDS activates RalA, which is necessary for WPB exocytosis (Rondaij2008Guanine).

RALGDS is primarily active in the cytoplasm and translocates to the plasma membrane upon activation by Ras, a small GTPase. This translocation is necessary for the activation of Ral proteins and is enhanced by interactions with calmodulin in a calcium-dependent manner (Matsubara1999Plasma; Rondaij2008Guanine). The protein also plays a role in cellular signaling pathways that influence cell proliferation, differentiation, and survival (Ferro2010RalGDS).

## Clinical Significance
Alterations in the expression of the RALGDS gene have significant clinical implications, particularly in the context of cancer. Elevated expression of RALGEFs, such as RALGDS, is associated with poor survival outcomes and increased local invasion and distant metastasis in various cancers. This is due to the role of RALGEFs in promoting the exchange of GDP for GTP, which activates RAL GTPases, leading to enhanced cancer cell invasion and migration (Richardson2022The). In pancreatic cancer, overexpression of RalGEF RGL2, a paralogue of RALGDS, is crucial for cancer cell growth and invasion, indicating a similar potential role for RALGDS in tumorigenesis (Shirakawa2015Ral).

The RalGEF-RalA pathway, in which RALGDS is involved, is essential for Ras-induced tumorigenesis and anchorage-independent growth in cancers such as colon cancer and melanoma. This pathway is more potent than other Ras-driven pathways in promoting tumorigenesis, highlighting the importance of Ral functions in human cancer (Shirakawa2015Ral). Additionally, RALGDS-null mice show resistance to skin tumors, suggesting that RALGDS-mediated Ral activation is important for Ras-induced tumorigenesis (Shirakawa2015Ral). These findings underscore the critical role of RALGDS in cancer progression and its potential as a therapeutic target.

## Interactions
RALGDS (ral guanine nucleotide dissociation stimulator) is known for its interactions with several small GTPases, including Ras and Ral proteins. RALGDS specifically interacts with the GTP-bound form of Ras p21, but not with its GDP-bound form, indicating a nucleotide-dependent interaction. This interaction occurs through the effector loop of Ras p21, and RALGDS can inhibit the interaction of Ras with other effector proteins like Raf-1 (Kikuchi1994ralGDS).

RALGDS also serves as a guanine nucleotide exchange factor (GEF) for RalA and RalB, linking Ras signaling to Ral activation. It interacts with Ras through its C-terminal Ras Binding Domain (RBD), which is essential for Ras-dependent activation of its guanine nucleotide exchange activity (Ferro2010RalGDS; Wang2015RILP).

In addition to its interactions with Ras and Ral, RALGDS interacts with other proteins such as PDK1 and beta-arrestin, which regulate the activation of the Ral pathway. It also interacts with Sec5 and Exo84 to mediate exocytosis in endothelial cells (Wang2015RILP). RALGDS's interaction with RILP can interfere with its GDP/GTP exchange activity, affecting cell migration and invasion (Wang2015RILP).


## References


[1. (Huang1996Crystallization) L. Huang, J. Jancarik, S.-H. Kim, F. Hofer, and G. S. Martin. Crystallization and preliminary crystallographic analysis of the ras binding domain of ralgds, a guanine nucleotide dissociation stimulator of the ral protein. Acta Crystallographica Section D Biological Crystallography, 52(5):1033–1035, September 1996. URL: http://dx.doi.org/10.1107/s0907444996003228, doi:10.1107/s0907444996003228. This article has 1 citations.](https://doi.org/10.1107/s0907444996003228)

[2. (Ferro2010RalGDS) Elisa Ferro and Lorenza Trabalzini. Ralgds family members couple ras to ral signalling and that’s not all. Cellular Signalling, 22(12):1804–1810, December 2010. URL: http://dx.doi.org/10.1016/j.cellsig.2010.05.010, doi:10.1016/j.cellsig.2010.05.010. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2010.05.010)

[3. (Gohlke2003Insights) Holger Gohlke, Christina Kiel, and David A. Case. Insights into protein–protein binding by binding free energy calculation and free energy decomposition for the ras–raf and ras–ralgds complexes. Journal of Molecular Biology, 330(4):891–913, July 2003. URL: http://dx.doi.org/10.1016/s0022-2836(03)00610-7, doi:10.1016/s0022-2836(03)00610-7. This article has 1024 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0022-2836(03)00610-7)

[4. (Wang2015RILP) Z Wang, Y Zhou, X Hu, W Chen, X Lin, L Sun, X Xu, W Hong, and T Wang. Rilp suppresses invasion of breast cancer cells by modulating the activity of rala through interaction with ralgds. Cell Death &amp; Disease, 6(10):e1923–e1923, October 2015. URL: http://dx.doi.org/10.1038/cddis.2015.266, doi:10.1038/cddis.2015.266. This article has 19 citations.](https://doi.org/10.1038/cddis.2015.266)

[5. (Shirakawa2015Ral) R. Shirakawa and H. Horiuchi. Ral gtpases: crucial mediators of exocytosis and tumourigenesis. Journal of Biochemistry, 157(5):285–299, March 2015. URL: http://dx.doi.org/10.1093/jb/mvv029, doi:10.1093/jb/mvv029. This article has 83 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/jb/mvv029)

[6. (Kikuchi1994ralGDS) Akira Kikuchi, Susan D. Demo, Zhi-Hai Ye, Yen-Wen Chen, and Lewis T. Williams. Ralgds family members interact with the effector loop of ras p21. Molecular and Cellular Biology, 14(11):7483–7491, November 1994. URL: http://dx.doi.org/10.1128/mcb.14.11.7483-7491.1994, doi:10.1128/mcb.14.11.7483-7491.1994. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.14.11.7483-7491.1994)

[7. (Richardson2022The) Dillon S. Richardson, Jonathan M. Spehar, David T. Han, Prathik A. Chakravarthy, and Steven T. Sizemore. The ral enigma: distinct roles of rala and ralb in cancer. Cells, 11(10):1645, May 2022. URL: http://dx.doi.org/10.3390/cells11101645, doi:10.3390/cells11101645. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells11101645)

[8. (Rondaij2008Guanine) Mariska G. Rondaij, Ruben Bierings, Ellen L. van Agtmaal, Karina A. Gijzen, Erica Sellink, Astrid Kragt, Stephen S. G. Ferguson, Koen Mertens, Matthew J. Hannah, Jan A. van Mourik, Mar Fernandez-Borja, and Jan Voorberg. Guanine exchange factor ralgds mediates exocytosis of weibel-palade bodies from endothelial cells. Blood, 112(1):56–63, July 2008. URL: http://dx.doi.org/10.1182/blood-2007-07-099309, doi:10.1182/blood-2007-07-099309. This article has 45 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2007-07-099309)

[9. (Matsubara1999Plasma) Kenji Matsubara, Shosei Kishida, Yoshiharu Matsuura, Hitoshi Kitayama, Makoto Noda, and Akira Kikuchi. Plasma membrane recruitment of ralgds is critical for ras-dependent ral activation. Oncogene, 18(6):1303–1312, February 1999. URL: http://dx.doi.org/10.1038/sj.onc.1202425, doi:10.1038/sj.onc.1202425. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1202425)

[10. (Albright1993Characterization) C.F. Albright, B.W. Giddings, J. Liu, M. Vito, and R.A. Weinberg. Characterization of a guanine nucleotide dissociation stimulator for a ras-related gtpase. The EMBO Journal, 12(1):339–347, January 1993. URL: http://dx.doi.org/10.1002/j.1460-2075.1993.tb05662.x, doi:10.1002/j.1460-2075.1993.tb05662.x. This article has 136 citations.](https://doi.org/10.1002/j.1460-2075.1993.tb05662.x)